EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Sydney Children's Hospital, Sydney

Rigshospitalet Department of Oncology Blegdamsvej, Copenhagen

The Childrens Hospital at Westmead Oncology Unit, Westmead

The Royal Children's Hospital, Melbourne

Lady Cilento/Queensland Children's Hospital, South Brisbane

Memorial Sloan Kettering, New York

Charite - Universitatsmedizin Berlin, Berlin

Istituto Giannina Gaslini- UOSD Centro di Neuro-Oncologia, Genova

Children's Hospital of Philadelphia, Philadelphia

Children's National Medical Center, Washington D.C.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

John Hopkins Kimmel Cancer Center, Baltimore

Children's Healthcare of Atlanta, Atlanta

St. Jude Children's Research Hospital, Inc., Memphis

Cincinnati Children's Hospital Medical Center, Cincinnati

Westfalische Wilhelms - Universitat Munster Padiatrische, Münster

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago

UT Southwestern Medical Center, Dallas

Institut Curie, Paris

Texas Children's Cancer and Hematology Center, Houston

Children's Hospital Colorado, Aurora

Children's Hospital Augsburg Klinikum, Augsburg

Children's Hospital of Los Angeles, Los Angeles

University of California San Francisco - Benioff Children's Hospital, San Francisco

Institut Gustave Roussy, Villejuif

Oregon Health & Science University (OHSU), Portland

Seattle Children's Hospital, Seattle

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital - Cancer Center, Boston

The Hospital for Sick Children, Toronto

Universitaetsklinikum Heidelberg, Heidelberg

Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam

Prinses Maxima Centrum voor Kinderoncologie, Utrecht

Great Ormond Street Hospital for Children NHS Foundation Trust, London

Central Manchester University Hospital - Royal Manchester Children's Hospital, Manchester